Caverject User Study

Pfizer

Status and phase: Completed; Phase 3

Conditions: Erectile Dysfunction

Treatments: Other: delivery system

Study type: Interventional

Funder types: Industry

Identifiers

NCT01008605

A6711035

Details and patient eligibility

About

The purpose of this study is to demonstrate the usability of the system.

Full description

demonstrate usability

Enrollment: 48 patients

Sex: Male

Ages: 40 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Age 40 to 70

Exclusion criteria

Prior syringe skills

Trial design

48 participants in 1 patient group

Caverject Impulse

Experimental group

Description:

representative users

Treatment:

Other: delivery system